Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,424 | 2 | 62.9% |
| Consulting Fee | $2,000 | 1 | 36.7% |
| Food and Beverage | $20.79 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,300 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $2,021 | 2 | $0 (2024) |
| CHIESI USA, INC. | $124.11 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,321 | 2 | ABBVIE INC. ($3,300) |
| 2020 | $2,000 | 1 | Merck Sharp & Dohme Corporation ($2,000) |
| 2018 | $124.11 | 1 | CHIESI USA, INC. ($124.11) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | — | Cash or cash equivalent | $3,300.00 | Research |
| Study: ULCERATIVE COLITIS (UC) VIRTUAL PANEL DISCUSSION • Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: VACCINE | ||||||
| 03/11/2020 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/11/2018 | CHIESI USA, INC. | — | — | Cash or cash equivalent | $124.11 | Research |
| Study: CLI-06563AA1-02 | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ULCERATIVE COLITIS (UC) VIRTUAL PANEL DISCUSSION | ABBVIE INC. | $3,300 | 1 |
| CLI-06563AA1-02 | CHIESI USA, INC. | $124.11 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 123 | 139 | $26,965 | $12,465 |
| 2022 | 2 | 102 | 132 | $23,370 | $10,692 |
| 2021 | 2 | 115 | 134 | $26,045 | $11,911 |
| 2020 | 3 | 184 | 212 | $39,325 | $18,722 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 69 | $16,905 | $7,389 | 43.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 54 | $7,020 | $3,482 | 49.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 16 | $3,040 | $1,594 | 52.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 53 | 54 | $13,230 | $6,068 | 45.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 78 | $10,140 | $4,624 | 45.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 74 | 75 | $18,375 | $8,337 | 45.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 59 | $7,670 | $3,574 | 46.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 97 | 98 | $24,010 | $11,308 | 47.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 76 | 103 | $13,390 | $6,438 | 48.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $1,925 | $975.64 | 50.7% |
About Dr. Walter Kraft, M.D
Dr. Walter Kraft, M.D is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003834177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Kraft, M.D has received a total of $5,445 in payments from pharmaceutical and medical device companies, with $3,321 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "" ($3,424).
As a Medicare-enrolled provider, Kraft has provided services to 524 Medicare beneficiaries, totaling 617 services with total Medicare billing of $53,791. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Clinical Pharmacology
- Location Philadelphia, PA
- Active Since 07/17/2006
- Last Updated 07/10/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003834177
Products in Payments
- SKYRIZI (Biological) $3,300
- MK-8591A (Drug) $2,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Philadelphia
Pitamber Devgon, Md, MD
Internal Medicine — Payments: $7.5M
Dr. David Horn, M.d, M.D
Internal Medicine — Payments: $1.7M
Daniel Rader, Md, MD
Internal Medicine — Payments: $1.6M
Corey Langer, Md, MD
Internal Medicine — Payments: $742,647
Dr. Intekhab Ahmed, M.d, M.D
Internal Medicine — Payments: $621,997
David Goldmann, Md, MD
Internal Medicine — Payments: $587,696